Related Experiment Video
Updated: Jul 7, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Nephrogenic systemic fibrosis: non-gadolinium options for the imaging of CKD/ESRD patients
1Department of Imaging, UCL Hospitals, London, United Kingdom. peter.dawson@uclh.nhs.uk
Abstract:
Nephrogenic systemic fibrosis (NSF) is a severe systemic disorder developing apparently exclusively in patients in advanced renal failure who receive a gadolinium chelate contrast-enhancing agent for magnetic resonance imaging. Some other apparent risk factors have been identified but their status remains uncertain. Physicians are frequently confronted with patients at risk of NSF who need imaging. An approach to planning imaging in patients at risk to develop NSF is outlined.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Imaging Studies VII: Vascular Imaging
Imaging Studies II: Ultrasonography
Imaging Studies III: Computed Tomography

